Ignacio Duran (I Duran, I Durán, Ignacio Durán)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 7

Top Topics

Acute Lymphoblastic Leukemia

Small Cell Lung Cancer

Prognostic Factors

Top Venues

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Therapeutic advances in urology

Pharmacogenomics

This page only lists publications with an associated author ORCID identifier.

Publications

Marta Sotelo, Nerea Muñoz-Unceta, Antonio Matorras, Pablo Jara, Clara Castro, Diego Cacho, Belén Caramelo, Ainara Azueta, Ignacio Duran
Outcomes with atezolizumab in metastatic urothelial cancer: real-world data from a single institution. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2023)
Marina Serrano, Nerea Muñoz-Unceta, Lucía Andrea Alonso, Ainara Azueta, José Luis Gutiérrez Baños, Laura Ferreira, Mario Domínguez, Albero Torres Zurita, Roberto Ballestero, Diego Cacho, Marta López-Brea, Marta Sotelo, Félix Campos-Juanatey, Enrique Ramos Barseló, Ignacio Duran
Neoadjuvant chemotherapy with dose-dense MVAC in muscle-invasive bladder cancer: a tertiary center experience. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2023)
Daniel Herrero Rivera, Carmen Garrigós Vacas, Laura Marcos Kovandzic, Javier Puente Vázquez, Lucía A Alonso, Begoña Mellado González, Verónica Calderero Aragón, Enrique Grande, Raquel Luque Caro, Juan A Virizuela Echaburu, Juan F Rodríguez Moreno, Ainara A Etxebarria, Cristina Rodríguez-Antona, Ignacio Duran
Single-nucleotide polymorphism associations with efficacy and toxicity in metastatic castration-resistant prostate cancer treated with cabazitaxel. Pharmacogenomics 23 (11) (2022)
Joerg Beyer, Laurence Collette, Nicolas Sauvé, Gedske Daugaard, Darren R Feldman, Torgrim Tandstad, Alexey A Tryakin, Olof Stahl, Enrique Gonzalez-Billalabeitia, Ugo De Giorgi, Stephane Culine, Ronald de Wit, Aaron Richard Hansen, Marko Bebek, Angelika Terbuch, Costantine Albany, Marcus Hentrich, Jourik A Gietema, Helene F S Negaard, Robert A Huddart, Anja Lorch, Fay H Cafferty, Daniel Y C Heng, Christopher J Sweeney, Eric Winquist, Michal Chovanec, Christian Daniel Fankhauser, Daniel Stark, Peter S Grimison, Andrea Necchi, Ben Tran, Axel Heidenreich, Jonathan Shamash, Cora N Sternberg, David J Vaughn, Ignacio Duran, Carsten Bokemeyer, Anna Patrikidou, Richard Cathomas, Samson Assele, Silke Gillessen Sommer, null null
Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (14) (2021)
M Sotelo, T Alonso-Gordoa, P Gajate, E Gallardo, R Morales-Barrera, J L Pérez-Gracia, J Puente, P Sánchez, D Castellano, Ignacio Duran
Atezolizumab in locally advanced or metastatic urothelial cancer: a pooled analysis from the Spanish patients of the IMvigor 210 cohort 2 and 211 studies. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 23 (4) (2020)
R Escudero-Ávila, J D Rodríguez-Castaño, I Osman, F Fernandez, R Medina, B Vargas, M Japón-Rodríguez, P Sancho, B Perez-Valderrama, J M Praena-Fernández, Ignacio Duran
Active surveillance as a successful management strategy for patients with clinical stage I germ cell testicular cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 21 (6) (2018)
Alfonso Gómez De Liaño, Ignacio Duran
The continuing role of chemotherapy in the management of advanced urothelial cancer. Therapeutic advances in urology 10 (12) (2018)